{"ok":true,"trend":{"id":408142,"platform":"mastodon","region":"global","key":"blockbuster retatrutide trial signals a 'new high-water mark' for weight-loss drugs https://www.scientificamerican.com/a","title":"Blockbuster retatrutide trial signals a 'new high-water mark' for weight-loss drugs https://www.scientificamerican.com/a","url":"https://www.scientificamerican.com/article/blockbuster-retatrutide-trial-signals-a-new-high-water-mark-for-weight-loss-drugs/","first_seen":"2026-09-29T22:07:49.399341Z","last_seen":"2026-09-29T23:29:49.296866Z","last_rank":6,"peak_rank":4,"last_volume":1,"peak_volume":1,"seen_count":2,"score":64.33,"category_hint":"health","section":"health","category":"health","summary":"A major clinical trial of retatrutide, Eli Lilly's experimental obesity drug, is being described as a 'new high-water mark' for weight-loss medications, according to Scientific American. The results suggest the drug may outperform existing GLP-1 treatments, fueling excitement among researchers and clinicians about the next generation of obesity therapies.","why":"New trial results suggest retatrutide could surpass current weight-loss drugs, drawing wide attention in the health community.","tone":"positive","entities":["retatrutide","Eli Lilly","Scientific American"],"summarized_at":"2026-09-29T22:08:29.228629Z","meta":{"tag":"health","via":"scan","kind":"status","lang":"en","instance":"mastodon.social","tag_uses":317},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Retatrutide trial hailed as new high-water mark for weight-loss drugs","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-09-29T22:07:49.399341Z","rank":4,"volume":1},{"captured_at":"2026-09-29T23:29:49.296866Z","rank":6,"volume":1}],"posts":[{"platform":"mastodon","url":"https://www.scientificamerican.com/article/blockbuster-retatrutide-trial-signals-a-new-high-water-mark-for-weight-loss-drugs/","author":"scientific_american@robot.villas","title":null,"snippet":"Blockbuster retatrutide trial signals a 'new high-water mark' for weight-loss drugs https://www.scientificamerican.com/article/blockbuster-retatrutide-trial-signals-a-new-high-water-mark-for-weight-loss-drugs/ # Science # Health # Medicine","posted_at":"2026-09-29T22:01:00Z","likes":1}],"elsewhere":[],"window":"7d"}}